Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Transverse myelitis.
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity.
Recent Gains in Clinical Multiple Sclerosis Research Review.
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Reliability and Factor Structure.
The role of mitochondria in axonal degeneration and tissue repair in MS.
TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.

Pages